Find out the difference between the production of carrier-added versus non-carrier-added lutetium-177, a radioisotope of choice for targeted radiopharmaceutical therapy.

Most medical-grade radionuclides used in synthesizing diagnostic and therapeutic radiopharmaceuticals are produced through one of the four methods of nuclear activation: fission, neutron activation, cyclotron and generator systems. Find out more in the infographic.​

The following slide kit outlines the principles and steps for somatostatin receptor-based imaging, specifically in managing neuroendocrine tumors.